Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity

JD Sperry, A Loeb, MJ Smith, TB Brighton… - Journal of Thrombosis …, 2024 - Springer
Abstract Background Direct oral anticoagulants (DOACs) are the preferred treatment for
venous thromboembolism (VTE). However, DOAC use in patients with a BMI greater than 40 …
被引用次数：1 相关文章

Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity.

JD Sperry, A Loeb, MJ Smith, TB Brighton… - … of Thrombosis and …, 2024 - europepmc.org
Background Direct oral anticoagulants (DOACs) are the preferred treatment for venous
thromboembolism (VTE). However, DOAC use in patients with a BMI greater than 40 kg/m 2 …

Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity

JD Sperry, A Loeb, MJ Smith… - … of thrombosis and …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) are the preferred treatment for venous
thromboembolism (VTE). However, DOAC use in patients with a BMI greater than 40 kg/m 2 …